`
`————————————————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`————————————————
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioners
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. and
`VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
`Patent Owners.
`————————————————
`
`Case: IPR2017-00190
`U.S. Patent No. 7,214,506
`
`————————————————
`
`
`
`ACRUX’S UNOPPOSED MOTION TO WITHDRAW COUNSEL AND
`SUBSTITUTE NEW COUNSEL
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`I.
`
`RELIEF REQUESTED
`
`Pursuant to 37 C.F.R. § 42.10(e), and as authorized by the Board via an
`
`email dated August 27, 2018 (see 37 C.F.R. § 42.20(b)), Petitioners Acrux DDS
`
`Pty Ltd. and Acrux Limited (“Acrux”) respectfully request authorization to
`
`withdraw prior counsel and substitute new counsel to transact all business in the
`
`United States Patent & Trademark Office associated with the Petition for Inter
`
`Partes Review of U.S. Patent No. 7,214,506 on behalf of Acrux. Counsel for
`
`Acrux has conferred with Patent Owner’s counsel, who has stated that Patent
`
`Owner will not oppose the present motion.
`
`II.
`
`STATEMENT OF REASONS FOR SUBSTITUTION OF COUNSEL
`
`Acrux wishes to be represented by new counsel in transacting all business in
`
`the United States Patent & Trademark Office associated with the Petition for Inter
`
`Partes Review of U.S. Patent No. 7,214,506. Acrux’s new counsel, identified
`
`below, meet the requirements of 37 C.F.R. § 42.10(c) as registered practitioners.
`
`Petitioner therefore designates the following counsel to transact all business in the
`
`USPTO associated with the above-captioned proceeding:
`
`Lead Counsel
`Tara M. Raghavan (Reg. No. 55,557)
`traghavan@rmmslegal.com
`Postal and Hand Delivery Address
`RAKOCZY MOLINO MAZZOCHI SIWIK
`LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`
`Backup Counsel
`Steven J. Birkos (Reg. No. 65,300)
`sbirkos@rmmslegal.com
`William A. Rakoczy
`(pro hac vice to be filed)
`wrakoczy@rmmslegal.com
`Joseph T. Jaros
`(pro hac vice to be filed)
`
`
`
`Tel: (312) 222-6340
`Fax: (312) 222-6341
`
`
`
`jjaros@rmmslegal.com
`Postal and Hand Delivery Address
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: (312) 222-5127
`Fax: (312) 222-6321
`
`
`
`
`No extensions of time will be needed upon grant of this Motion. It is
`
`believed that granting this Motion will not hinder the economy, the integrity of the
`
`patent system, the efficient administration of the Office, or the ability of the Office
`
`to timely complete this proceeding. See 35 U.S.C. § 316(b).
`
`An executed updated Power of Attorney and updated Mandatory Notices
`
`Under 37 C.F.R. § 42.83(b)(3) are being filed concurrently herewith.
`
`
`
`
`
`
`Dated: August 28, 2018
`
`
`
`By:
`
`Respectfully submitted,
`
`Respectfully submitted,
`
`/Aydin H. Harston/
`E. Anthony Figg, Reg. No. 27,195
`Aydin H. Harston, Reg. No. 65,249
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040
`Fax: 202-783-6031
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true and correct copy of Acrux’s
`
`Motion To Withdraw Counsel and Substitute New Counsel was served on
`
`August 28, 2018, via electronic mail by agreement of the parties, on the following:
`
`John D. Livingstone
`Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363-6209
`john.livingstone@finnegan.com
`KakenIPR@finnegan.com
`
`Naoki Yoshida
`naoki.yoshida@finnegan.com
`Anthony Hartman
`anthony.hartman@finnegan.com
`Barbara R. Rudolph, Ph.D.
`barbara.rudolph@finnegan.com
`Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.
`901 New York Ave., NW
`Washington, DC 20001-4413
`
`Toan P. Vo
`toan.vo@bausch.com
`Valeant Pharmaceuticals North America LLC
`1400 N. Goodman Street
`Rochester, New York 14609
`
`Teresa Staneck Rea
`TRea@Crowell.com
`Shannon M. Lentz
`SLentz@Crowell.com
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Ave, NW
`Washington, DC 2004-2595
`
`
`
`
`
`
`
`
`Tyler C. Liu
`TLiu@agpharm.com
`Argentum Pharmaceuticals, LLC
`
`
`
`
`Dated: August 28, 2018
`
`
`
`By:
`
`
`
`
`Respectfully submitted,
`
`/Aydin H. Harston/
`E. Anthony Figg, Reg. No. 27,195
`Aydin H. Harston, Reg. No. 65,249
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040
`Fax: 202-783-6031
`
`
`
`